Trial Profile
Phase II trial: Pre-operative, long-term chemoradiation with capecitabine, oxaliplatin and bevacizumab in locally advanced rectal cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Oct 2012
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms BevXelOx-RT
- 03 Oct 2012 Integrated information from European Clinical Trials Database record (EudraCT2007-001558-21)
- 05 Jun 2008 New trial record.